COMMUNIQUÉS West-GlobeNewswire
-
Healthwise Recognized for Plain-Language Excellence With 2018 Grand ClearMark Award
14/05/2018 - 12:00 -
Fennec Provides Business Update and Announces First Quarter 2018 Financial Results
14/05/2018 - 12:00 -
Amphastar Pharmaceuticals Receives FDA Approval for Calcium Chloride Injection
14/05/2018 - 12:00 -
International Endeavors Corporation, a Medical Marijuana IP Holdings Company, Secures a $500,000 Investment Commitment From Voltage River
14/05/2018 - 12:00 -
Invitation: Terveystalo result audiocast and conference call on 16 May 2018
14/05/2018 - 10:21 -
Xbrane Biopharma and Episurf invites to a company presentation in Stockholm May 29
14/05/2018 - 09:49 -
Sanofi and Ablynx Announce the Successful Results of the Initial Tender Offer Period for Ablynx and Commencement of Squeeze-Out Tender Period
14/05/2018 - 08:10 -
mise à jour: Sanofi et Ablynx annoncent le succès des offres publiques d'acquisition sur Ablynx et le lancement d'offres de reprise
14/05/2018 - 08:10 -
Xbrane Biopharma releases interim report for the first quarter of 2018
14/05/2018 - 08:01 -
Sanofi and Ablynx Announce the Successful Results of the Initial Tender Offer Period for Ablynx and Commencement of Squeeze-Out Tender Period
14/05/2018 - 08:01 -
Sanofi et Ablynx annoncent le succès des offres publiques d'acquisition sur Ablynx et le lancement d'offres de reprise
14/05/2018 - 08:01 -
SANOFI AND ABLYNX ANNOUNCE THE SUCCESSFUL RESULTS OF THE INITIAL TENDER OFFER PERIOD FOR ABLYNX AND COMMENCEMENT OF SQUEEZE-OUT TENDER PERIOD
14/05/2018 - 08:01 -
Vistin Pharma ASA : Commencement of subscription period for the subsequent repair issue
14/05/2018 - 08:00 -
ERYTECH Strengthens Executive Team with the Appointment of Alex Dusek as VP of Commercial Strategy
14/05/2018 - 07:30 -
PledPharma has completed the recruitment for the clinical trial with Aladote®
14/05/2018 - 07:30 -
Fagron NV: Disclosure of received notification
14/05/2018 - 07:01 -
Radius Health to Present at the Bank of America Merrill Lynch 2018 Annual Healthcare Conference
12/05/2018 - 02:09 -
Novartis announces FDA approval of Gilenya® as the first disease-modifying therapy for pediatric relapsing multiple sclerosis
12/05/2018 - 00:25 -
New Study Demonstrates Feasibility of Novel Mechanical Sensor in Medtronic Micra Transcatheter Pacing System to Detect Atrial Contractions and Restore AV Synchrony
11/05/2018 - 23:16
Pages